Stock Yards Bank & Trust Co. lowered its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,160 shares of the company’s stock after selling 100 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Clorox were worth $3,437,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC increased its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares in the last quarter. Quarry LP increased its position in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $48,000. Institutional investors own 78.53% of the company’s stock.
Clorox Stock Down 1.2 %
Shares of CLX stock opened at $158.60 on Monday. The company has a market capitalization of $19.63 billion, a price-to-earnings ratio of 55.26, a PEG ratio of 2.91 and a beta of 0.42. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company’s fifty day moving average price is $162.76 and its 200-day moving average price is $158.35. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.
Clorox Announces Dividend
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on CLX shares. Barclays dropped their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $156.07.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- How to Use the MarketBeat Stock Screener
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- Insider Trades May Not Tell You What You Think
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.